Carmel, IN, United States of America

Kevin Dale Seibert

This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Dale Seibert. Retrieved from https://idiyas.com/inventor/kevin-dale-seibert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2012-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kevin Dale Seibert: Innovator in Pharmaceutical Processes

Introduction

Kevin Dale Seibert is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes and intermediates for drug manufacturing. With a total of 2 patents, Seibert's work has the potential to impact the medical industry positively.

Latest Patents

Seibert's latest patents include innovative processes for preparing tirzepatide and arzoxifene. The first patent focuses on new intermediates and processes useful in the manufacture of tirzepatide, or a pharmaceutically acceptable salt thereof. The second patent provides for novel compounds of formula I, wherein specific groups are selected to create effective processes for preparing arzoxifene.

Career Highlights

Kevin Dale Seibert is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and healthcare solutions. His work at Eli Lilly has allowed him to contribute to groundbreaking research and development in the pharmaceutical sector.

Collaborations

Seibert collaborates with talented professionals in his field, including coworkers Michael E Kopach and Rachel Nicole Richey. These collaborations enhance the innovative processes and research efforts within the company.

Conclusion

Kevin Dale Seibert's contributions to pharmaceutical processes exemplify the importance of innovation in drug development. His patents and work at Eli Lilly and Company highlight his role as a key player in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…